Randomized trial shows tomato-soy juice reduces inflammatory protein levels in obese adults — Evidence Review

Drinking a tomato-soy juice high in plant compounds for four weeks reduced key inflammatory markers in healthy adults with obesity, according to a new study from The Ohio State University. Related research generally supports the anti-inflammatory potential of tomato and soy-based dietary interventions, though results across diverse populations and long-term outcomes remain mixed.

• Several human and animal studies have found that tomato-derived lycopene and soy isoflavones can lower pro-inflammatory cytokines and improve metabolic health, consistent with the new findings 1 2.
• Broader reviews show that plant-based and Mediterranean-style diets—which often include tomatoes and soy—are associated with reduced inflammation and improved chronic disease risk, suggesting these foods may contribute to overall dietary benefits 3 4 5.
• However, systematic reviews emphasize that evidence quality varies and that more controlled intervention trials are needed to confirm specific effects of tomato-soy combinations and clarify their role in different chronic diseases 5 7.

Study Overview and Key Findings

Chronic low-grade inflammation is a central factor in the development of many long-term diseases, including cardiovascular disease, type 2 diabetes, and certain cancers. The potential for food-based interventions to modulate inflammatory processes is an area of growing scientific and public health interest. This new study stands out for its use of a rigorously controlled design to directly compare the effects of a tomato-soy juice enriched with lycopene and soy isoflavones to a control juice, examining not only inflammatory protein levels but also metabolic changes in healthy adults with obesity.

Property	Value
Study Year	2026
Organization	The Ohio State University
Journal Name	Molecular Nutrition & Food Research
Authors	Maria J. Sholola, Jenna Miller, Emma A. Bilbrey, Janet A. Novotny, David M. Francis, Thomas A. Mace, Jessica L. Cooperstone
Population	Healthy adults with obesity
Sample Size	n=12
Methods	Randomized Controlled Trial (RCT)
Outcome	Inflammatory protein levels, urinary metabolome changes
Results	Tomato-soy juice significantly lowered inflammatory protein levels.

Literature Review: Related Studies

To contextualize these findings, we searched the Consensus paper database—which includes over 200 million research papers—using targeted queries for studies on tomato-soy juice, inflammation, and dietary interventions for chronic disease. The following queries were used to identify relevant literature:

1. tomato-soy juice inflammation reduction
2. anti-inflammatory effects of tomato-soy
3. dietary interventions chronic disease inflammation

Related Studies: Key Topics and Findings

Topic	Key Findings
What evidence is there that tomato or tomato-soy interventions reduce inflammation?	- Tomato juice consumption reduces inflammatory cytokines in overweight and obese individuals, supporting risk reduction for inflammation-linked diseases 1. - Preclinical models show soy-tomato diets reduce inflammatory markers and disease severity in chronic pancreatitis 2.
How do plant-based dietary patterns influence inflammation and chronic disease risk?	- Plant-based and Mediterranean diets are associated with lower inflammation and oxidative stress biomarkers, potentially aiding in chronic disease prevention 3 4 5. - High-fiber plant-based diets improve microbiome diversity and reduce inflammation, especially in type 2 diabetes 6.
What are the limitations and strengths of dietary intervention studies for inflammation?	- Evidence quality varies, with many intervention studies rated as low-to-moderate quality and showing inconsistent results across populations 5 7. - Some meta-analyses identify the Mediterranean diet as most effective for lowering inflammatory biomarkers; effects of other patterns are less clear 5 7.
Do dietary interventions have specific benefits in disease contexts like pancreatitis or IBD?	- Soy-tomato enriched diets reduce inflammation and disease severity in animal models of chronic pancreatitis, suggesting potential for symptom management 2. - Dietary interventions show potential in inflammatory bowel disease, but evidence remains limited and certainty is low 7.

What evidence is there that tomato or tomato-soy interventions reduce inflammation?

Several studies support the idea that tomato-derived compounds, including lycopene, can reduce inflammatory markers in humans, particularly among overweight and obese populations. Animal models further demonstrate that combining soy and tomato bioactives can lessen disease severity and lower cytokine levels in chronic inflammatory conditions. The current study builds on these findings by rigorously testing a tomato-soy juice in a randomized controlled human trial focused on obesity-linked inflammation.

• Human RCTs show that daily tomato juice intake can significantly reduce levels of inflammatory cytokines such as IL-8 and TNF-α in overweight and obese women 1.
• In preclinical models, soy-tomato diets decrease pro-inflammatory cytokines and immune cell populations in chronic pancreatitis, leading to reduced disease severity 2.
• The new study's findings of reduced inflammatory proteins (IL-5, IL-12p70, GM-CSF) after tomato-soy juice intake align with these prior results 1 2.
• The combination of lycopene and isoflavones in food-based interventions may offer additive or synergistic anti-inflammatory benefits, warranting further investigation 2.

How do plant-based dietary patterns influence inflammation and chronic disease risk?

Reviews and large cohort studies consistently find that plant-based dietary patterns, including Mediterranean and DASH diets, are associated with lower levels of systemic inflammation and reduced risk for major chronic diseases. Tomatoes and soy are common components of such diets, and their individual bioactive compounds may contribute to these broader effects.

• Systematic reviews link Mediterranean and plant-based diets to reductions in oxidative stress and proinflammatory biomarkers 3 4 5.
• High-fiber plant-based interventions improve gut microbiome diversity and decrease markers of inflammation, particularly in type 2 diabetes 6.
• The anti-inflammatory effects observed with tomato-soy juice may reflect, in part, the benefits of plant-rich dietary patterns documented in these broader studies 3 4 5 6.
• Adherence to low-inflammatory diets correlates with lower incidence of cardiovascular disease, diabetes, and cancer in large observational studies 4.

What are the limitations and strengths of dietary intervention studies for inflammation?

While many studies suggest that dietary interventions can modulate inflammation, systematic reviews highlight methodological limitations, including small sample sizes, short durations, and variability in outcome measures. The current study addresses some of these challenges through its randomized, controlled design and targeted biomarker analysis, but its small sample size and short intervention period remain limiting factors.

• Meta-analyses show that the Mediterranean diet produces the most consistent reductions in inflammatory biomarkers, but other diets studied in RCTs yield less robust or inconsistent effects 5.
• Many dietary intervention trials are rated as low-to-moderate quality, often due to design limitations, heterogeneity, and risk of bias 5 7.
• The evidence base for specific foods or combinations (e.g., tomato-soy juice) is still emerging, with limited high-quality RCTs in humans 5 7.
• Larger, longer-term studies are needed to confirm the findings and determine their relevance for chronic disease prevention 5 7.

Do dietary interventions have specific benefits in disease contexts like pancreatitis or IBD?

Research into dietary interventions for specific inflammatory diseases is ongoing, with some promising results in preclinical and small-scale human studies. For instance, soy-tomato diets have been shown to reduce inflammation and disease severity in animal models of chronic pancreatitis, and dietary modification may offer symptom relief in inflammatory bowel disease, although the quality of evidence remains low.

• In mice, soy-tomato enriched diets reduce pancreatic inflammation, fibrosis, and pain-related behaviors, supporting further clinical investigation in humans with pancreatitis 2.
• Dietary interventions for inflammatory bowel disease (IBD) show potential, but meta-analyses rate the certainty of evidence as low or very low, indicating a need for more robust trials 7.
• The new clinical trial in adults with obesity and the planned trial in pancreatitis patients represent important steps toward clarifying the therapeutic potential of tomato-soy bioactives 2 7.
• Dietary strategies may need to be tailored to specific disease contexts and patient populations to optimize anti-inflammatory effects 2 7.

Future Research Questions

While this study adds important evidence supporting the anti-inflammatory effects of tomato-soy juice in adults with obesity, further research is necessary to clarify its long-term impact, effectiveness in diverse populations, and mechanisms of action. Key areas for future investigation include clinical relevance for chronic disease outcomes, optimal formulations and dosages, and the interplay with gut microbiome changes.

Research Question	Relevance
What are the long-term effects of tomato-soy juice consumption on chronic disease risk?	Establishing the sustained impact of tomato-soy juice on inflammation and disease incidence is critical for public health recommendations; current studies are short-term and focused on biomarkers rather than outcomes 4 5.
Does tomato-soy juice reduce inflammation in populations with existing chronic inflammatory diseases?	Most research has focused on healthy or at-risk individuals; testing in patients with diseases such as pancreatitis or inflammatory bowel disease could clarify therapeutic potential 2 7.
How do lycopene and soy isoflavones act synergistically to modulate immune function?	Understanding the mechanisms and potential synergy could inform dietary guidelines and the development of functional foods targeting inflammation 2.
What is the role of the gut microbiome in the anti-inflammatory effects of tomato-soy juice?	High-fiber plant-based diets impact microbiome diversity and inflammation; investigating this link in the context of tomato-soy juice could reveal important mediating pathways 6.
Are the anti-inflammatory effects of tomato-soy juice consistent across different demographic groups?	Variations in response by age, sex, ethnicity, or baseline health status may influence the generalizability of findings and require targeted research 1 4.

---

This article presents a comprehensive, evidence-based overview of the latest study on tomato-soy juice and inflammation, situating the findings within the broader scientific literature and highlighting areas for future research.